Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ODP
3351
DELISTED
ODP
ODP
| $3.11M | ﹤0.01% |
106,187
-158,219
| -60% | -$4M |
|
3352
4D Molecular Therapeutics
FDMT
$562M
| $3.11M | ﹤0.01% |
+74,978
| New | +$3.1M |
|
3353
Kadant
KAI
$3.99B
| $3.1M | ﹤0.01% |
21,997
+16,644
| +311% | +$2.12M |
|
3354
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
| $3.1M | ﹤0.01% |
38,060
+2,617
| +7% | +$201K |
|
3355
Granite Construction
GVA
$5.62B
| $3.09M | ﹤0.01% |
115,697
-139,768
| -55% | -$3.21M |
|
|
IGAC
3356
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
| $3.09M | ﹤0.01% |
+305,000
| New | +$3.05M |
|
|
CORE
3357
DELISTED
Core Mark Holding Co., Inc.
CORE
| $3.08M | ﹤0.01% |
105,036
-55,770
| -35% | -$1.71M |
|
|
FFG
3358
DELISTED
FBL Financial Group
FFG
| $3.08M | ﹤0.01% |
58,714
-40,064
| -41% | -$2.06M |
|
3359
Anika Therapeutics
ANIK
$287M
| $3.08M | ﹤0.01% |
67,987
-32,643
| -32% | -$1.24M |
|
3360
Tactile Systems Technology
TCMD
$665M
| $3.07M | ﹤0.01% |
68,409
-89,847
| -57% | -$3.57M |
|
|
INN
3361
Summit Hotel Properties
INN
$700M
| $3.07M | ﹤0.01% |
340,282
-261,725
| -43% | -$1.94M |
|
3362
Matsons
MATX
$6.18B
| $3.06M | ﹤0.01% |
53,784
-63,714
| -54% | -$3.48M |
|
3363
BioNTech
BNTX
$23.5B
| $3.05M | ﹤0.01% |
37,449
+26,685
| +248% | +$2.62M |
|
|
MSP
3364
DELISTED
Datto Holding Corp.
MSP
| $3.04M | ﹤0.01% |
+112,771
| New | +$3.2M |
|
3365
Standard BioTools
LAB
$314M
| $3.03M | ﹤0.01% |
505,248
+403,091
| +395% | +$2.65M |
|
3366
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $3.03M | ﹤0.01% |
20,000
-187,900
| -90% | -$26.9M |
|
3367
CALL
Mondelez International
MDLZ
$79.9B
| $3.03M | ﹤0.01% |
51,800
-105,500
| -67% | -$6.03M |
|
|
JRO
3368
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $3.02M | ﹤0.01% |
348,796
| – | – |
|
|
BMY.RT
3369
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.02M | ﹤0.01% |
4,374,383
-535,342
| -11% | -$1.14M |
|
|
GLS
3370
DELISTED
Gelesis Holdings, Inc.
GLS
| $3.02M | ﹤0.01% |
+297,000
| New | +$2.92M |
|
3371
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $3.01M | ﹤0.01% |
+132,268
| New | +$2.81M |
|
3372
Otter Tail
OTTR
$3.94B
| $3.01M | ﹤0.01% |
70,685
+10,762
| +18% | +$439K |
|
|
RCM
3373
DELISTED
R1 RCM Inc. Common Stock
RCM
| $3.01M | ﹤0.01% |
125,407
-128,195
| -51% | -$2.55M |
|
|
ABST
3374
DELISTED
Absolute Software Corp
ABST
| $3.01M | ﹤0.01% |
+252,606
| New | +$2.75M |
|
|
ALEX
3375
DELISTED
Alexander & Baldwin
ALEX
| $3M | ﹤0.01% |
174,728
-111,343
| -39% | -$1.62M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.